Table 2.

Growth of parental PEL cells and their EBV convertants in SCID mice


Cell line

Virus

Dose

Route

No. of mice with tumors/total inoculated
BC-3   HHV-8   10 × 106  SC   0/9  
BC-3 GFP EBV cl-6   HHV-8 + EBV   10 × 106  SC   8/9  
BC-3 GFPEBV cl-10   HHV-8 + EBV   10 × 106  SC   1/6  
CRO-AP/6   HHV-8   1 × 106  SC   0/6  
   3 × 106  SC   0/6  
   10 × 106  SC   6/6  
CRO-AP/6 GFPEBV cl-1   HHV-8 + EBV   1 × 106  SC   6/6  
   3 × 106  SC   6/6  

 

 
10 × 106
 
SC
 
6/6
 

Cell line

Virus

Dose

Route

No. of mice with tumors/total inoculated
BC-3   HHV-8   10 × 106  SC   0/9  
BC-3 GFP EBV cl-6   HHV-8 + EBV   10 × 106  SC   8/9  
BC-3 GFPEBV cl-10   HHV-8 + EBV   10 × 106  SC   1/6  
CRO-AP/6   HHV-8   1 × 106  SC   0/6  
   3 × 106  SC   0/6  
   10 × 106  SC   6/6  
CRO-AP/6 GFPEBV cl-1   HHV-8 + EBV   1 × 106  SC   6/6  
   3 × 106  SC   6/6  

 

 
10 × 106
 
SC
 
6/6
 

SCID mice, aged 4 to 5 weeks, were inoculated with indicated tumor cells. SC indicates subcutaneous.

Close Modal

or Create an Account

Close Modal
Close Modal